Literature DB >> 15853707

Recent developments in the identification of chemotherapeutics for Chagas disease.

Jeffrey W Lockman1, Andrew D Hamilton.   

Abstract

Chagas Disease, caused by the T. cruzi parasite, is one of the largest public health problems in the Western hemisphere. Although its spread has diminished due to vector eradication programs, effective chemotherapeutics for the disease itself remain elusive. Many efforts towards the development of antiparasitic agents active against a number of targets have been described recently in the literature. This review summarizes developments in trypanosidal agents from 2000 through 2003.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15853707     DOI: 10.2174/0929867053507289

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  4 in total

1.  The use of violacein to study biochemical behaviour of Saccharomyces cerevisiae cells.

Authors:  Ricardo de Souza Pereira; Nelson Durán; Pedro L O Volpe
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Oct-Dec       Impact factor: 2.441

2.  In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.

Authors:  Yen Ting Chen; Linda S Brinen; Iain D Kerr; Elizabeth Hansell; Patricia S Doyle; James H McKerrow; William R Roush
Journal:  PLoS Negl Trop Dis       Date:  2010-09-14

3.  Optimization and Evaluation of Antiparasitic Benzamidobenzoic Acids as Inhibitors of Kinetoplastid Hexokinase 1.

Authors:  Daniel P Flaherty; Michael T Harris; Chad E Schroeder; Haaris Khan; Elizabeth W Kahney; Amber L Hackler; Stephen L Patrick; Warren S Weiner; Jeffrey Aubé; Elizabeth R Sharlow; James C Morris; Jennifer E Golden
Journal:  ChemMedChem       Date:  2017-11-16       Impact factor: 3.466

4.  Pharmacophore modeling for anti-Chagas drug design using the fragment molecular orbital method.

Authors:  Ryunosuke Yoshino; Nobuaki Yasuo; Daniel Ken Inaoka; Yohsuke Hagiwara; Kazuki Ohno; Masaya Orita; Masayuki Inoue; Tomoo Shiba; Shigeharu Harada; Teruki Honma; Emmanuel Oluwadare Balogun; Josmar Rodrigues da Rocha; Carlos Alberto Montanari; Kiyoshi Kita; Masakazu Sekijima
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.